Medscape Medical News
- FDA Approves Remdesivir, First Treatment for COVID-19
- Alert FDA OKs Combo Therapy for First-Line Mesothelioma Treatment
- FDA Expands Polyarticular-Course JIA Indications for Tofacitinib
- Alert FDA OKs Mepolizumab (Nucala) for Hypereosinophilic Syndrome
- Alert FDA OKs First Point-of-Care Antibody Test for COVID-19
- Alert FDA Clears New Neurosurgical Port for Deep Brain Access
- Alert Pralsetinib: Second Drug for RET+ NSCLC Approved in US
- Alert FDA OKs Somapacitan (Sogroya), First Once-Weekly Growth Hormone
- Alert FDA Approves First Maintenance Therapy for AML
- Alert FDA OKs New 'Artificial Pancreas' Medtronic 770G
- Alert FDA Approves Point-of-Care COVID-19 Antigen Test
- Alert FDA Approves Topical Antiandrogen for Acne
- Alert FDA Clears First Brain Stimulation Device to Help Smokers Quit
- Alert FDA OKs Ofatumumab (Kesimpta) for Relapsing Forms of MS
- FDA OKs Satralizumab (Enspryng) for NMOSD
- Alert FDA OKs Viltolarsen (Viltepso) for Duchenne Muscular Dystrophy
- Alert FDA Approves IV Opioid Oliceridine for Short-term Use
- Alert FDA Approves First Liquid Biopsy/NGS Test for Lung Cancer
- Alert FDA OKs First Oral Treatment for Spinal Muscular Atrophy
- Alert FDA Approves Belantamab in R/R Multiple Myeloma